CO6460760A2 - Tia-triaza-ciclopentazulenos - Google Patents

Tia-triaza-ciclopentazulenos

Info

Publication number
CO6460760A2
CO6460760A2 CO11154168A CO11154168A CO6460760A2 CO 6460760 A2 CO6460760 A2 CO 6460760A2 CO 11154168 A CO11154168 A CO 11154168A CO 11154168 A CO11154168 A CO 11154168A CO 6460760 A2 CO6460760 A2 CO 6460760A2
Authority
CO
Colombia
Prior art keywords
ciclopentazulenos
triaza
tia
remainder
medicine
Prior art date
Application number
CO11154168A
Other languages
English (en)
Inventor
Der Veen Lars Van
Maria Impagnatiello
Darryl Mcconnell
Siegfried Schneider
Tobias Wunberg
Original Assignee
Boehringer Ingelheim Internat Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Internat Gmbh filed Critical Boehringer Ingelheim Internat Gmbh
Publication of CO6460760A2 publication Critical patent/CO6460760A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención comprende compuestos de fórmula general (1)En la quede R1 a R3 y X se definen como en la reivindicación 1, que son adecuados para el tratamiento de enfermedades caracterizadas por una proliferación celular excesiva o anormal, y el uso de los mismos para preparar un medicamento que tenga las propiedades mencionadas anteriormente.
CO11154168A 2009-04-22 2011-11-11 Tia-triaza-ciclopentazulenos CO6460760A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09158493 2009-04-22

Publications (1)

Publication Number Publication Date
CO6460760A2 true CO6460760A2 (es) 2012-06-15

Family

ID=40996623

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11154168A CO6460760A2 (es) 2009-04-22 2011-11-11 Tia-triaza-ciclopentazulenos

Country Status (21)

Country Link
US (1) US8288379B2 (es)
EP (1) EP2421871B1 (es)
JP (1) JP5658231B2 (es)
KR (1) KR20120014152A (es)
CN (1) CN102459282A (es)
AP (1) AP2011005893A0 (es)
AR (1) AR076364A1 (es)
AU (1) AU2010240965A1 (es)
BR (1) BRPI1016174A2 (es)
CA (1) CA2759595A1 (es)
CO (1) CO6460760A2 (es)
EA (1) EA201101537A1 (es)
EC (1) ECSP11011464A (es)
IL (1) IL215199A0 (es)
MA (1) MA33223B1 (es)
MX (1) MX2011011065A (es)
SG (1) SG175746A1 (es)
TN (1) TN2011000530A1 (es)
TW (1) TW201103942A (es)
UY (1) UY32566A (es)
WO (1) WO2010122071A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160091060A (ko) 2015-01-23 2016-08-02 전관식 약제 분배장치 및 분말약 분배방법
ITRM20150212A1 (it) * 2015-05-15 2016-11-15 Univ Degli Studi Di Palermo 4,5,6,9-tetraidropirrolo[2',3':3,4] cicloepta[1,2-d] isossazoli, procedimento per la loro produzione e loro uso come antitumorali

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9024A (en) * 1852-06-15 Motion of the lay in looms
US5547975A (en) * 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
UY29149A1 (es) 2004-10-07 2006-05-31 Boehringer Ingelheim Int Tiazolil-dihidro-indazoles
KR20070064660A (ko) 2004-10-07 2007-06-21 베링거 인겔하임 인터내셔날 게엠베하 Ｐｉ３ 키나제
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
US9243000B2 (en) * 2009-04-22 2016-01-26 Boehringer Ingelheim International Gmbh Thia-triaza-indacenes

Also Published As

Publication number Publication date
EP2421871B1 (en) 2015-09-16
AR076364A1 (es) 2011-06-08
AP2011005893A0 (en) 2011-10-31
JP2012524751A (ja) 2012-10-18
TW201103942A (en) 2011-02-01
IL215199A0 (en) 2011-12-29
SG175746A1 (en) 2011-12-29
EP2421871A1 (en) 2012-02-29
US8288379B2 (en) 2012-10-16
ECSP11011464A (es) 2011-12-30
TN2011000530A1 (en) 2013-05-24
US20110112087A1 (en) 2011-05-12
CA2759595A1 (en) 2010-10-28
UY32566A (es) 2010-11-30
EA201101537A1 (ru) 2012-05-30
MA33223B1 (fr) 2012-04-02
AU2010240965A1 (en) 2011-10-20
MX2011011065A (es) 2011-11-04
JP5658231B2 (ja) 2015-01-21
BRPI1016174A2 (pt) 2016-04-19
CN102459282A (zh) 2012-05-16
KR20120014152A (ko) 2012-02-16
WO2010122071A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
UY33199A (es) 5-alquinil-pirimidinas.
ECSP099823A (es) Nuevos compuestos químicos
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
ECSP12011830A (es) Nuevos compuestos.
UY32009A (es) 5-alquinil-pirimidinas
ECSP088932A (es) Nuevos compuestos químicos
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
ECSP13012448A (es) Nuevas aminopirazoloquinazolinas.
ECSP11010816A (es) Nuevos Compuestos
UY32240A (es) Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
UY32494A (es) Nuevas 2,4-diaminopirimidinas, sales farmacéuticas de las mismas, composiciones conteniéndolas y aplicaciones
UY33890A (es) Nuevas azaindolilfenil sulfonamidas como inhibidores de serina/ treonina cinasa
ECSP11010930A (es) Nuevos compuestos químicos
ECSP088905A (es) Nuevos compuestos
PE20151023A1 (es) Triazolopirazinas
CU20150062A7 (es) Lactamas n-(heteroarilo sustituido) fusionadas utiles en el tratamiento del crecimiento celular anormal
UY31982A (es) Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
UY33817A (es) ?nuevas oxindolpirimidinas bencílicas?.
UY31138A1 (es) Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones
ECSP11011558A (es) Nuevos compuestos químicos.
CO6290768A2 (es) Tiazolil-dihidro-indazoles
CO6460762A2 (es) 5-alquinil-piridinas
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.

Legal Events

Date Code Title Description
FA Application withdrawn